Scott T. Garrett
CIK: 0001231174
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HCW Biologics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 22, 2026HCWB
HCW Biologics Inc.
Purchase(P)Indirect177.9K shares at avg. $1.41$250K - May 16, 2025HCWB
HCW Biologics Inc.
Purchase(P)Direct13.4K shares at avg. $7.45$100K - May 8, 2025HCWB
HCW Biologics Inc.
Purchase(P)Direct5.4K shares at avg. $26.00$140K - May 7, 2025HCWB
HCW Biologics Inc.
Purchase(P)DirectCommon Stock Purchase Warrant
2.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 22, 2026 | HCWB HCW Biologics Inc. | Purchase(P) | 177,936 | $1.41 | $250,000 | Indirect |
| May 16, 2025 | HCWB HCW Biologics Inc. | Purchase(P) | 13,423 | $7.45 | $100,001 | Direct |
| May 8, 2025 | HCWB HCW Biologics Inc. | Purchase(P) | 5,385 | $26.00 | $140,010 | Direct |
| May 7, 2025 | HCWB HCW Biologics Inc. | Purchase(P) Common Stock Purchase Warrant | 2,692 | - | - | Direct |
1-4 of 4 transactions
About GARRETT SCOTT T
GARRETT SCOTT T (SEC CIK 0001231174) files insider reports with the SEC as Director of HCW Biologics Inc. (HCWB).
Signal8 holds 3 ownership filings by GARRETT SCOTT T, all Form 4s, filed between May 9, 2025 and May 27, 2026. Those filings report 4 transactions, from May 7, 2025 to May 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GARRETT SCOTT T's filings is in MIRAMAR,, FL.
Recent filings by GARRETT SCOTT T
Other insiders filing for HCW Biologics Inc. (HCWB)
- Wong Hing C, Chief Executive Officer
- Byam Rebecca, Chief Financial Officer
- Winer Gary M, Director
- Flowers Lee, SVP of Business Development
- Greene Rick S., Director